Skip to main content
Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism and disposition. The journal serves as an international forum for the publication of timely reviews in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments. The journal covers the following areas:

In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; recent developments for the identification of drug metabolites and adducts.

Publisher: Bentham Science Publishers

More about this publication?
Volume 2, Number 4, 2001

Book Reviews

Preface
pp. i-i(1)
Author: Sadzuka, Y.

Favourites:
ADD

Reviews

Favourites:
ADD

Contribution of Specific Transport Systems to Anthracycline Transport in Tumor and Normal Cells
pp. 355-366(12)
Authors: Nagasawa, K.; Nagai, K.; Ohinishi, N.; Yokoyama, T.; Fujimoto, S.

Favourites:
ADD

The MRP Family and Anticancer Drug Metabolism
pp. 367-377(11)
Authors: Suzuki, T.; Nishio, K.; Tanabe, S.

Favourites:
ADD

Effect of Methylxanthine Derivatives on Doxorubicin Transport and Antitumor Activity
pp. 379-395(17)
Authors: Kakuyamanee Iwazaki, A.; Sadzuka, Y.

Favourites:
ADD

Interactions of Liposomes with Cells In Vitro and In Vivo: Opsonins and Receptors
pp. 397-409(13)
Authors: Ishida, T.; Harashima, H.; Kiwada, H.

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content